Intra-Cellular Therapies Plans Financial Results Discussion
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI), a leading biopharmaceutical company dedicated to developing treatments for central nervous system (CNS) disorders, has announced an upcoming conference call and live webcast slated for the morning of October 30, 2024. The call is scheduled to commence at 8:30 a.m. Eastern Time, where company executives will provide substantial updates and discuss the financial performance for the quarter that ended on September 30, 2024.
Details of the Upcoming Conference
Participants interested in attending the call via phone must complete an online registration process using the provided link ahead of the event. This will ensure a seamless experience as Intra-Cellular Therapies prepares to share critical insights and performance metrics. Attendees are advised to log in approximately 5 to 10 minutes before the scheduled start to register and download any necessary software for the webcast.
How to Join the Call
By following the registration link, potential attendees will complete the necessary steps to secure their participation in this important discussion. The conference call will not only delve into financial results but also offer a broader perspective on the company’s strategic directions and innovations in the treatment of psychiatric and neurologic diseases.
About Intra-Cellular Therapies
Intra-Cellular Therapies is groundbreaking in its approach, stemming from Nobel Prize-winning research that aims to unlock new therapeutic pathways within human cells. This biopharmaceuticals firm focuses on the potential complexities of CNS disorders and is committed to advancing treatment options that can significantly enhance the quality of life for patients. With a commitment to innovation, the company is paving the way for revolutionary therapies aimed at some of the most challenging healthcare issues.
Commitment to Innovation and Research
The innovative mindset of Intra-Cellular Therapies stems from its dedication to understanding how internal cellular processes can be utilized to combat various disorders. This scientific approach is what sets the company apart in the biopharmaceutical arena, enabling it to explore new therapeutic options that could lead to improved outcomes in CNS treatment and management.
Company Contact Information
For those interested in further information or press inquiries, Intra-Cellular Therapies encourages reaching out to their Vice President, Corporate Communications, and Investor Relations, Dr. Juan Sanchez. Dr. Sanchez can provide additional insights and is reachable at 646-440-9333. Alternatively, for media inquiries, Cameron Radinovic from Burns McClellan, Inc. is available at 646-930-4406 or through email.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call is intended to provide a corporate update and discuss financial results for Intra-Cellular Therapies.
When is the conference call scheduled?
The call is set for October 30, 2024, at 8:30 a.m. Eastern Time.
How can I access the webcast?
Participants can access the webcast through the Investors section on Intra-Cellular Therapies’ website.
Who should I contact for more information about the event?
For detailed inquiries regarding the event, you can contact Dr. Juan Sanchez or Cameron Radinovic for assistance.
What is the focus of Intra-Cellular Therapies?
The company focuses on the development of therapeutics for central nervous system disorders through an innovative cellular approach.